Skip to content

Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational Runners

Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational Runners

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02996786
Enrollment
39
Registered
2016-12-19
Start date
2016-10-31
Completion date
2017-07-31
Last updated
2018-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue, Hemolysis, Inflammation, Iron Deficiency, Oxidative Stress, Sports Anemia

Brief summary

The aim of this study is to examine the beneficial effects of Danggui Buxue Tang on blood biochemical parameters in male recreational runners.

Detailed description

1. Male recreational runners would be recruited by community websites or email. After completely introducing the study, the participants would be requested to sign informed consent. 2. The participants would perform maximal oxygen consumption test prior to the supplementation. The participants would be supplemented with either Danggui Buxue Tang or placebo for a week before performing the 13-km run. A total of 4 times blood collection (before supplementation, immediate after running, 1 day and 3 days after running) would be performed for evaluating the effect of Danggui Buxue Tang on blood biochemical parameters.

Interventions

DIETARY_SUPPLEMENTDanggui Buxue Tang

Danggui Buxue Tang purchased from Kaiser Pharmaceutical

OTHERPlacebo

Consisting of corn starch and carboxymethyl cellulose

Sponsors

Kaohsiung Medical University Chung-Ho Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
20 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* The participants should have the experience finishing 10-km run but without the experience of attending a marathon run.

Exclusion criteria

* Participants suffering from anemia (Hb \<13 g/dL), taking usual supplements, medication, alcohol or not feeling comfortable.

Design outcomes

Primary

MeasureTime frameDescription
Hematological parametersThrough study completion, an average of 1 yearComplete blood counts and serum haptoglobin and erythropoietin
Iron statusThrough study completion, an average of 1 yearSerum iron, ferritin, transferrin and hepcidin
Oxidative stressThrough study completion, an average of 1 yearThiobarbituric acid reactive substances, superoxide dismutase, catalase, and glutathione peroxidase
Inflammatory responseThrough study completion, an average of 1 yearHigh-sensitivity c-reactive protein, Tumor necrosis factor-alpha, and interleukin-6

Secondary

MeasureTime frameDescription
Running timeThrough study completion, an average of 1 yearThe completion time for a 13-km run

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026